Board of Directors

Catherine Beech OBE

Dr Catherine Beech was formerly the European Medical Director of a multi-national pharmaceutical company and brings a broad range of expertise in drug development, clinical programmes and the requirements of both patients and healthcare providers. She also has a background in early stage venture capital and was a co-founder … Continue reading →

Matthew young

Matthew Young founded Oval Medical in 2009 to develop devices that provided radical improvements in the safety, acceptability and reliability of needle-based self-administration of drugs. He has more than 10 years’ experience working with a leading medical product development consultancy. … Continue reading →

Steve Dawson

Steve joined the board as a non-executive director in January 2010, with a background in delivering commercially viable products from revolutionary technology across a broad range of industries … Continue reading →

Peter Keen

Peter Keen is a chartered accountant with over 26 years’ experience in technology businesses, primarily within the life sciences. He was part of the founding management team of Chiroscience Group plc and then a co-founder of the VC firm Merlin Biosciences where he was UK Managing Director. … Continue reading →

Barbara Lead

Barbara Lead has over twenty years’ experience in leading pharmaceutical companies, having worked in the asthma and allergy therapy area with a number of companies including Fisons, Rhone Poulenc Rorer, Orion Pharma and Akela Pharma. … Continue reading →

Phil O'Donovan

Dr Phil O’Donovan is a Co-Founder of CSR plc which listed on the London Stock Exchange in March 2004, became a FTSE 250 company in July of the same year, and is now Europe’s largest fabless semiconductor … Continue reading →

Jerry Turner

Jerry has extensive engineering and international commercial experience in the medical device sector.

He is Chief Executive Officer of Team Consulting Limited, a leading medical device development consultancy, entirely … Continue reading →

Olivier Fourment

Olivier Fourment Olivier Fourment has been the President of Aptar Pharma since 2008. From 2000-2008, he was Co-President of the Company’s Valois Group and President of Valois’ Pharma division. Prior to 2000, Mr. Fourment held various sales and marketing positions within the Valois Pharma division… Continue reading →